The review concluded that combining neurotrophic and glutamatergic markers—such as BDNF, NTRK2, and GRIN2A/2B—may enhance the precision of predictive models in TRD and support the future development of multi-omic frameworks in personalized psychiatry. Here, GRIN2A is linked to treatment resistant depression.